Continuous dopaminergic stimulation by Duodopa® in advanced Parkinson's disease: Efficacy and safety;Intérêts de la stimulation dopaminergique continue par Duodopa® dans la maladie de Parkinson évoluée : efficacité et tolérance

Revue Neurologique

Volumn 165, Issue 8-9, 2009, Pages 718-727

  Annic, A ^a   Devos, D ^a   Seguy, D ^b   Dujardin, K ^a   Destee A ^a   Defebvre, L ^a  

^a EA2683   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

Brain stimulation; Duodopa ; Parkinson's disease

Indexed keywords

ANTIPARKINSON AGENT; APOMORPHINE; CARBIDOPA PLUS LEVODOPA; CLOZAPINE; DOMPERIDONE; DOPAMINE; LEVODOPA;

ADULT; AGED; ARTICLE; BRAIN DEPTH STIMULATION; CLINICAL ARTICLE; COGNITIVE DEFECT; CONFUSION; CONTINUOUS INFUSION; DOPAMINE RELEASE; DRUG EFFICACY; DRUG SAFETY; DYSKINESIA; FEMALE; GAIT; GASTROJEJUNOSTOMY; GOLD STANDARD; HALLUCINATION; HUMAN; MALE; MOTOR DYSFUNCTION; NEUROPSYCHOLOGICAL TEST; PARKINSON DISEASE; PSYCHOSIS; QUALITY OF LIFE; STOMACH TUBE; VISUAL HALLUCINATION;

AGED; ANTIPARKINSON AGENTS; CARBIDOPA; DEMENTIA; DRUG COMBINATIONS; DYSKINESIAS; FEMALE; GAIT; HUMANS; INTUBATION, GASTROINTESTINAL; LEVODOPA; MALE; MIDDLE AGED; MOVEMENT; PARKINSON DISEASE; QUALITY OF LIFE;

EID: 70049112141     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurol.2008.11.017     Document Type: Article

References (27)

1. Ahlskog J.E., and Muenter M.D. Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature. Mov Disord 16 (2001) 448-458
2. Anaes. Conférence de consensus du 3 mars 2000. La maladie de Parkinson : critères diagnostiques et thérapeutiques. Texte de recommandation.
3. Antonini A. Continuous dopaminergic stimulation-From theory to clinical practice. Parkinsonism Relat Disord 13 (2007) 24-28
4. Antonini A., Isaias I.U., Canesi M., et al. Duodenal levodopa infusion for advanced Parkinson's disease: 12-month treatment outcome. Mov Disord 22 (2007) 1145-1149
5. Defer G.L. Surgical treatment: inclusion criteria. Rev Neurol (Paris) 156 (2000) 251-256
6. Derkinderen P., and Vidailhet M. Dyskinésies provoquées par la Ldopa. Rev Neurol (Paris) 158 (2002) S92-S101
7. Destée A. Parkinson's disease: what therapeutic strategy is advisable in early stage disease?. Rev Neurol (Paris) 156 (2000) 109-118
8. Deuschl G., Schade-Brittinger C., Krack P., et al. A randomized trial of deep-brain stimulation for Parkinson's disease. N Engl J Med 355 (2006) 896-908
9. Drapier S., and Vérin M. Continuous subcutaneous infusion of apomorphine for the treatment of Parkinson's disease. Rev Neurol (Paris) 162 (2006) 1019-1023
10. Gan J., Xie-Brustolin J., Mertens P., et al. Bilateral subthalamic nucleus stimulation in advanced Parkinson's disease: three years follow-up. J Neurol 254 (2007) 99-106
11. Garcia Ruiz P.J., Sesar Ignacio A., Ares Pensado B., et al. Efficacy of long-term continuous subcutaneousapomorphine infusion in advanced Parkinson's disease with motor fluctuations: a multicenter study. Mov Disord 23 (2008) 1130-1136
12. Giladi N., Shabtai H., Simon E.S., Biran S., Tal J., and Korczyn A.D. Construction of freezing of gait questionnaire for patients with Parkinsonism. Parkinsonism Relat Disord 6 (2000) 165-170
13. Katzenschlager R., Hughes A., Evans A., et al. Continuous subcutaneous apomorphine therapy improves dyskinesias in Parkinson's disease: a prospective study using single-dose challenges. Mov Disord 20 (2005) 151-157
14. Kenney C., Simpson R., Hunter C., et al. Short-term and long-term safety of deep brain stimulation in the treatment of movement disorders. J Neurosurg 106 (2007) 621-625
15. Krack P., Batir A., Van Blercom N., et al. Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med 349 (2003) 1925-1934
16. Limousin P., Krack P., Pollak P., Benazzouz A., Ardouin C., Hoffmann D., and Benabid A.L. Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med 339 (1998) 1105-1111
17. Moro E., Scerrati M., Romito L.M., Roselli R., Tonali P., and Albanese A. Chronic subthalamic nucleus stimulation reduces medication requirements in Parkinson's disease. Neurology 53 (1999) 85-90
18. Nilsson D., Nyholm D., and Aquilonius S.M. Duodenal levodopa infusion in Parkinson's disease--long-term experience. Acta Neurol Scand 104 (2001) 343-348
19. Nilsson D., Hansson L.E., Johansson K., Nyström C., Paalzow L., and Aquilonius S.M. Long-term intraduodenal infusion of a water based levodopa-carbidopa dispersion in very advanced Parkinson's disease. Acta Neurol Scand 97 (1998) 175-183
20. Nyholm D., Nilsson D., Remahl A.I., et al. Duodenal levodopa infusion monotherapy vs oral polypharmacy in advanced Parkinson disease. Neurology 64 (2005) 216-223
21. Nyholm D., Askmark H., Gomes-Trolin C., Knutson T., Lennernäs H., Nyström C., and Aquilonius S.M. Optimizing levodopa pharmacokinetics: intestinal infusion versus oral sustained-release tablets. Clin Neuropharmacol 26 (2003) 156-163
22. Pietz K., Hagell P., and Odin P. Subcutaneous apomorphine in late stage Parkinson's disease: a long term follow up. J Neurol Neurosurg Psychiatry 65 (1998) 709-716
23. Poewe W., and Wenning G.K. Apomorphine: an underutilized therapy for Parkinson's disease. Mov Disord 15 (2000) 789-794
24. Schüpbach W.M., Chastan N., Welter M.L., et al. Stimulation of the subthalamic nucleus in Parkinson's disease: a 5 year follow up. J Neurol Neurosurg Psychiatry 76 (2005) 1640-1644
25. Stefani C.V., Drapier S., Peron J., Sauleau P., and Verin M. Continuous Subcutaneous Apomorphine Infusion: an Effective and Cognitive Well-Tolerated Solution for Untreatable Motor Fluctuations in Patients with Parkinson's Disease. Neurology (abstract) 64 (2005) A396
26. Thobois S., Mertens P., Guenot M., et al. Subthalamic nucleus stimulation in Parkinson's disease: clinical evaluation of 18 patients. J Neurol 249 (2002) 529-534
27. Tir M., Devos D., Blond S., et al. Exhaustive, one-year follow-up of subthalamic nucleus deep brain stimulation in a large, single-center cohort of parkinsonian patients. Neurosurgery 61 (2007) 297-304